Kamal Hamed
Chief Tech/Sci/R&D Officer at SPERO THERAPEUTICS, INC.
Net worth: 1 M $ as of 2024-04-29
Profile
Kamal Hamed is currently the Chief Medical Officer at Spero Therapeutics, Inc. Prior to this, he worked as the Chief Medical Officer at Lysovant Sciences, Inc. Hamed holds a graduate degree from The Johns Hopkins University, an MBA from the University of South Florida, and a doctorate from the American University of Beirut.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
SPERO THERAPEUTICS, INC.
1.46% | 2024-02-01 | 788,117 ( 1.46% ) | 1 M $ | 2024-04-29 |
Kamal Hamed active positions
| Companies | Position | Start |
|---|---|---|
| SPERO THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2022-09-14 |
Former positions of Kamal Hamed
| Companies | Position | End |
|---|---|---|
| Lysovant Sciences, Inc. | Chief Tech/Sci/R&D Officer | - |
Training of Kamal Hamed
| The Johns Hopkins University | Graduate Degree |
| University of South Florida | Masters Business Admin |
| American University of Beirut | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| SPERO THERAPEUTICS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
| Lysovant Sciences, Inc. |
- Stock Market
- Insiders
- Kamal Hamed
